Pfizer to End Direct Funding of Medical Education Courses

In a move widely seen as an attempt to lessen criticism, Pfizer is halting its funding of medical education courses. The courses which had been funded by Pfizer and other pharmaceutical companies were widely seen by industry professionals as a marketing tool during which the drug companies could showcase their line of products under the guise of continued medical education. Fortunately for the consumer, the public outcry reached a level that Pfizer’s public relations machine decided it no longer made sense to offer the courses to the doctors.